Witjes WP - Search Results

1

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: witjes wp, witjes ja. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

2

BCG-RIVM versus BCG-Tice versus mitomycin-C in superficial bladder cancer. Rationale, design, and interim analysis of the trial of the South-East Cooperative Urological Group, The Netherlands.

Witjes WP, van der Meijden PM, Roos EP, Witjes JA, Steerenberg PA, Doesburg W, Debruyne FM. Witjes WP, et al. Among authors: witjes ja. Prog Clin Biol Res. 1992;378:59-67. Prog Clin Biol Res. 1992. PMID: 1301587 Clinical Trial. No abstract available.

3

Current status of neoadjuvant therapy in localized prostate cancer.

Witjes WP, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Prostate. 1995 Dec;27(6):297-303. doi: 10.1002/pros.2990270602. Prostate. 1995. PMID: 7501541 Review. No abstract available.

4

The value of neoadjuvant therapy in localized prostate cancer.

Witjes WP, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Int J Urol. 1995 Mar;2(1):1-5. doi: 10.1111/j.1442-2042.1995.tb00611.x. Int J Urol. 1995. PMID: 7614403 Free article. Review. No abstract available.

5

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: witjes wp, witjes ja. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

6

A multicentre trial of combined neoadjuvant androgen blockade with Zoladex and flutamide prior to radical prostatectomy in prostate cancer. The European Study Group on Neoadjuvant Treatment.

Debruyne FM, Witjes WP, Schulman CC, van Cangh PJ, Oosterhof GO. Debruyne FM, et al. Among authors: witjes wp. Eur Urol. 1994;26 Suppl 1:4. doi: 10.1159/000475423. Eur Urol. 1994. PMID: 7737257 Clinical Trial. No abstract available.

7

Overview of current status of total androgen deprivation in metastasized prostate cancer.

Debruyne FM, Witjes WP. Debruyne FM, et al. Among authors: witjes wp. Eur Urol. 1993;24 Suppl 2:67-71. Eur Urol. 1993. PMID: 8262129 Review.

8

Neoadjuvant therapy in prostate cancer--is it of any use?

Witjes WP, Horenblas S, Oosterhof GO, Schaafsma HE, Debruyne FM. Witjes WP, et al. Eur Urol. 1993;24(4):433-7. doi: 10.1159/000474346. Eur Urol. 1993. PMID: 8287884 Review.

9

Overview of the current status of total androgen deprivation in metastasized prostate cancer.

Debruyne FM, Witjes WP. Debruyne FM, et al. Among authors: witjes wp. World J Urol. 1993;11(4):233-6. doi: 10.1007/BF00185076. World J Urol. 1993. PMID: 8312942 Review. No abstract available.

10

A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1 tumours and primary carcinoma in situ of the urinary bladder. Dutch South-East Cooperative Urological Group.

Witjes JA, vd Meijden AP, Witjes WP, Doesburg W, Schaafsma HE, Debruyne FM. Witjes JA, et al. Among authors: witjes wp. Eur J Cancer. 1993;29A(12):1672-6. doi: 10.1016/0959-8049(93)90102-l. Eur J Cancer. 1993. PMID: 8398292 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page